🇺🇸 FDA
Patent

US 9919040

Soluble recombinant plasmodium falciparum circumsporozoite protein, use in vaccines, methods of making and uses thereof

granted A61KA61K2039/55566A61K39/015

Quick answer

US patent 9919040 (Soluble recombinant plasmodium falciparum circumsporozoite protein, use in vaccines, methods of making and uses thereof) held by The United States of America as represented by the Secretary of the Army expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/55566, A61K39/015